YUKIN THERAPEUTICS
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-ÎșB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept in animal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.
YUKIN THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Biot, Provence-Alpes-Cote D'Azur, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M EUR
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
GoLiver Therapeutics
GoLiver Therapeutics is specialized in the development of Innovative Therapy Medicines to meet an unmet urgent medical.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Current Employees Featured
Founder
Investors List
Medicxi
Medicxi investment in Venture Round - Yukin Therapeutics
AdBio partners
AdBio partners investment in Venture Round - Yukin Therapeutics